The global photodynamic therapy market size was valued at USD 4.3 billion in 2023 and is projected to reach around USD 8.42 billion by 2033, growing at a CAGR of 7% from 2024 to 2033.
Key Takeaways
- North America dominated the photodynamic therapy market with the largest share of 31% in 2023.
- By product type, the photosensitizers drugs segment held the largest share of the market in 2023.
- By light source, the lasers segment dominated the market in 2023.
- By application, the cancer segment has the largest share in the photodynamic therapy market in 2023.
- By end-user, the hospitals segment dominated the market in 2023.
The Photodynamic Therapy (PDT) market is a dynamic and evolving sector within the healthcare and medical technology industry. PDT is a non-invasive treatment modality that utilizes photosensitizing agents, light, and oxygen to selectively destroy or control diseased cells. This innovative approach has gained significant attention in recent years for its potential in treating various medical conditions, including cancer and certain dermatological disorders.
Get a Sample: https://www.precedenceresearch.com/sample/3737
Growth Factors
The market for Photodynamic Therapy is experiencing substantial growth due to several key factors. Firstly, advancements in research and technology have led to the development of more efficient photosensitizing agents and targeted light delivery systems, enhancing the therapeutic efficacy of PDT. Additionally, the growing prevalence of cancer and skin-related disorders worldwide has increased the demand for alternative and less invasive treatment options, further propelling the adoption of PDT.
Furthermore, the increasing awareness among both healthcare professionals and patients about the benefits of PDT, such as minimal side effects and reduced recovery times, has contributed to its widespread acceptance. Moreover, ongoing clinical trials exploring new applications of PDT and expanding regulatory approvals for existing treatments are driving the market’s growth trajectory.
Photodynamic Therapy Market Scope
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 7% |
Global Market Size in 2023 | USD 4.3 Billion |
Global Market Size by 2033 | USD 8.42 Billion |
U.S. Market Size in 2023 | USD 1.33 Billion |
U.S. Market Size by 2033 | USD 2.66 Billion |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product Type, By Light Source, By Application, and By End User |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Image Recognition Market Size to Worth USD 166.01 Bn by 2033
Opportunities
The Photodynamic Therapy market presents several opportunities for stakeholders. The rising incidence of cancer, especially skin cancers, provides a significant growth avenue. Moreover, as the technology matures, there is potential for PDT to be integrated into multidisciplinary treatment approaches, offering more comprehensive solutions for patients with complex medical conditions. Collaborations between pharmaceutical companies, research institutions, and healthcare providers can further drive innovation and create opportunities for novel applications of PDT.
The expanding geriatric population, which is more susceptible to certain medical conditions that can be addressed by PDT, presents an additional growth opportunity. Furthermore, the market could benefit from increased investment in awareness campaigns, educating both healthcare professionals and the general public about the advantages of Photodynamic Therapy.
Challenges
Despite its promising prospects, the Photodynamic Therapy market faces challenges. One significant hurdle is the need for further research and development to optimize treatment protocols, enhance the selectivity of photosensitizing agents, and address potential adverse effects. Reimbursement issues and the high initial costs associated with PDT equipment may also impede its widespread adoption, particularly in regions with limited healthcare resources.
Another challenge is the competition from conventional treatment modalities, such as surgery, radiation therapy, and chemotherapy, which have established track records and are deeply ingrained in clinical practices. Overcoming skepticism within the medical community and establishing PDT as a mainstream therapeutic option will require concerted efforts in research, education, and collaboration.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Photodynamic Therapy Market Companies
- Gladerma S.A.
- Sun Pharmaceutical Industries Ltd.
- Biofrontera
- Novartis AG
- Valeant Pharmaceuticals International, Inc.
- Quest Pharmatech, Inc.
- Hologic, Inc.
- Lumibird (Quantel Medical)
- Theralase Technologies Inc.
- Photocure ASA
- Biolitec AG
- IPG Photonics Corporation
Segments Covered in the Report
By Product Type
- Photosensitizer Drugs
- Photodynamic Therapy Devices
By Light Source
- Lasers
- Light Emitting Diodes (LEDs)
- Lamps
- Others
By Application
- Cancer
- Actinic Keratosis (AK)
- Psoriasis
- Acne
- Others
By End User
- Hospitals
- Cancer Treatment Centers
- Cosmetic and Dermatology Clinics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Photodynamic Therapy Market
5.1. COVID-19 Landscape: Photodynamic Therapy Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Photodynamic Therapy Market, By Product Type
8.1. Photodynamic Therapy Market, by Product Type, 2024-2033
8.1.1. Photosensitizer Drugs
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Photodynamic Therapy Devices
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Photodynamic Therapy Market, By Light Source
9.1. Photodynamic Therapy Market, by Light Source, 2024-2033
9.1.1. Lasers
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Light Emitting Diodes (LEDs)
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Lamps
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Photodynamic Therapy Market, By Application
10.1. Photodynamic Therapy Market, by Application, 2024-2033
10.1.1. Cancer
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Actinic Keratosis (AK)
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Psoriasis
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Acne
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Photodynamic Therapy Market, By End User
11.1. Photodynamic Therapy Market, by End User, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Cancer Treatment Centers
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cosmetic and Dermatology Clinics
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Photodynamic Therapy Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.1.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by End User (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.2.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by End User (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.3.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by End User (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.4.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by End User (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Light Source (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2033)
Chapter 13. Company Profiles
13.1. Gladerma S.A.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Sun Pharmaceutical Industries Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Biofrontera
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Novartis AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Valeant Pharmaceuticals International, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Quest Pharmatech, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Hologic, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Lumibird (Quantel Medical)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Theralase Technologies Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Photocure ASA
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/